Metraipolis › archive › dc_d73af2e7cbf7

Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma — Europe PMC PMID:42390726

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42390726
DOI
10.1007/s10147-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-07T20:30:43.561Z
SHA-256 of the archived text
38f9808500c6de5d75c798f97df6a2e207119eeeee1e7ca40eee4faf73f8d3a2
Stable URL of this page
https://metraipolis.com/documento/dc_d73af2e7cbf7

How to cite

Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma — Europe PMC PMID:42390726 — Europe PMC (en), https://europepmc.org/article/MED/42390726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d73af2e7cbf7 (Metraipolis archive dc_d73af2e7cbf7, sha256 38f9808500c6de5d75c798f97df6a2e207119eeeee1e7ca40eee4faf73f8d3a2)
BibTeX
@misc{dcd73af2e7cbf7,
  title = {Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma — Europe PMC PMID:42390726},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42390726},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d73af2e7cbf7; sha256 38f9808500c6de5d75c798f97df6a2e207119eeeee1e7ca40eee4faf73f8d3a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42390726. Agents can read the archived copy with the MCP tool read_document.